 - Patients who have had chemotherapy, biologic therapy, radiotherapy, or an experimental investigational agent within 4 weeks 6 weeks for nitrosoureas or mitomycin C prior to starting treatment or those who have not recovered from adverse events due to agents administered more than 4 weeks earlier. 